Biotechnology News

September 19, 2012

BOSTON--(BUSINESS WIRE)--SpringLeaf Therapeutics hires Pieter Muntendam, MD, as its President and CEO to advanced the Company's breakthrough technology that transforms the administration of non-orally administered medication.

September 19, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its Molecular Biology Center of Excellence in Vilnius, Lithuania.

September 19, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) announced that Chief Executive Officer Michael D. West, Ph.D. will present at the Stem Cells USA & Regenerative Medicine Congress 2012 in Cambridge, MA on Thursday, September 20...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide Inc., a medical device company specializing in precision surgical energy instruments, recently announced the launch of a next-generation product designed for laparoscopic endometriosis procedures. The...

September 19, 2012

DEERFIELD, Ill. & NEWTOWN, Pa.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) and Onconova Therapeutics, Inc. today announced that they have entered into a European licensing agreement for rigosertib, a novel targeted anti-cancer...

September 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The most important factor for drug companies when partnering with a companion diagnostics (CDx) developer is its technological capabilities, according to a recent study by Cutting Edge Information....

September 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug companies eager to work with end-users find patient communication to be the leading external difficulty for marketing teams, according to a recent study by Cutting Edge Information.

September 19, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen named to FierceBiotech's 2012 Fierce 15. Honor reflects company's commitment to develop innovative microRNA (miRNA)-based therapeutics to address disease areas of high unmet medical need.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seaside Therapeutics Inc. announced that FierceBiotech has selected the Company as one of the 2012 Fierce 15, designating it as one of the most promising private companies in the biotech industry.

September 19, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Receives Initial $2.9 million from Warrant Exchange Offer

September 19, 2012

SEATTLE--(BUSINESS WIRE)--Cadence Biomedical, a developer of medical devices that help people with severe disabilities walk, today announced the launch and commercial availability of its first product, the Kickstart™ Kinetic Orthosis. Kickstart...

September 19, 2012

LOS ANGELES--(BUSINESS WIRE)--Fidelis Diagnostics, Inc. Expands Operations to Colorado; Sabrina Bayles Tapped as Manager for New Denver Office

September 19, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of Illumina, is a leading provider of solutions...

September 19, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem propels its Independent Data Monitoring Committee, Data Safety Monitoring Board and Clinical Endpoint/Event Committee services with oversight by adding Dr. Lisa Moore.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FierceBiotech Names Foundation Medicine as One of 2012’s Fierce 15

September 19, 2012

TORONTO--(BUSINESS WIRE)--he growing population suffering from obesity, diabetes and hypertension will lead to increased incidence of both acute and chronic wounds, and thus favor adoption of wound care biomaterials in the US.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FierceBiotech today named bluebird bio as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth annual Fierce 15...

September 19, 2012

BASEL, Switzerland--(BUSINESS WIRE)--FierceBiotech today named Okairos as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry

September 19, 2012

SHARSHERET, Israel--(BUSINESS WIRE)--Morflora (www.morflora.com), focused on innovative non-transgenic trait delivery technology for plant protection reports today that its TraitUP™...

September 19, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals initiates Phase 3 study of ZEVALIN in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

September 19, 2012

JERUSALEM--(BUSINESS WIRE)--Gamida Cell, a leader in adult stem cell expansion technologies and products, announced today that it has completed enrollment for a Phase I/II clinical trial of NiCord, the company’s second pipeline product. NiCord is...

September 19, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today there will be a presentation on the mechanism of action of Capesaris® to induce sex hormone binding globulin (SHBG) and subsequently reduce free testosterone (FT) in men...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem appoints Louise Phanstiel to its Board of Directors.

September 19, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a leader in Assisted Reproductive Technologies (ART), announced that they have received 510k clearance for their Multipurpose Handling Medium™ product (MHM™) in the United States. The new MHM...

September 19, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals (OTCBB: PVCT) to Report Final Efficacy Data on Melanoma at ESMO 2012

September 19, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a global leader in Assisted Reproductive Technologies (ART), announced that they have received 510(k) clearance for their Continuous Single Culture™ - Complete product (CSCM-C). The company...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scientia Advisors appoints health economics, policy & reimbursement expert Randy Goodman Manager of Pricing and Market Access Group.

September 19, 2012

TAMPA BAY, Fla.--(BUSINESS WIRE)--News briefs concerning economic and business growth in the Tampa Bay region from the Tampa Bay Partnership.

September 19, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Initiates Talks to Acquire License for NASA Bioreactor Technology

September 19, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (publ.)(STO:RAYB) has entered into an exclusive license agreement with University Health Network’s Princess Margaret Cancer Centre in Toronto, Canada regarding techniques for...

September 19, 2012

CHICHESTER, England--(BUSINESS WIRE)--Proveris Scientific UK Limited expands operations and further executes on its commitment to serving the orally inhaled and spray drug product markets in Europe and Asia.

September 19, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (“Biomet”) announced an amendment to its previously announced tender offer (“Tender Offer”) to purchase for cash its outstanding 10% Senior Notes due 2017 (CUSIP Nos. 090613AC4; 550785AA7; U55004AA0) (...

September 18, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the three months ended...

September 18, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) today confirmed that it will cease repurchasing shares under the Normal Course Issuer Bid (NCIB) which will be cancelled effective as of September 19, after close of markets....

September 18, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Dividend

September 18, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the UBS Global Life Sciences Conference in New York. John F. Milligan, PhD, Gilead’s President and...

September 18, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Innovative microbiological bioburden testing system recognized at ABA’s First Tech and New Product Awards Ceremony in San Francisco

September 18, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Devon Medical Products has received approval from Medicare's Pricing, Data Analysis, and Coding (PDAC) contractor for its extriCARE™ 2400 Negative Pressure Wound Therapy (NPWT) pump and accessories.

September 18, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates announced it has been awarded a contract with NIDA to carry out clinical pharmacology studies to determine the pharmacokinetics & pharmacodynamics of new medications in humans.

September 18, 2012

TORONTO--(BUSINESS WIRE)--The US orthopedic soft tissue solutions market will be driven largely by a growing number of sports-related injuries.

September 18, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's 2012 CRO Quality Benchmarking report provides novel insight into the service quality of several Phase IV CROs.

September 18, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--A new, free white paper assists research institutions with the challenges of implementing biosafety level (BSL) 2+ practices and procedures in laboratory facilities.

September 18, 2012

SHREWSBURY, Mass.--(BUSINESS WIRE)--Join us in Cambridge, MA or Raleigh, NC to learn about small-scale single-use bioreactors coupled with continuous on-line measurement of glucose, viability, and more.

September 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales for schizophrenia therapies will drop from $7.4 billion in 2011 to $6.5...

September 18, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that rheumatologists in Germany and Spain indicated they have prescribed GlaxoSmithKline...

September 18, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/gnom) is investigating potential claims against the board of directors of...

September 18, 2012

COLUMBUS, Ohio--(BUSINESS WIRE)--Enlyton has secured funding from the National Cancer Institute for development of a novel imaging agent that will enable oncologists to produce more accurate scans in SPECT imaging of cancer.

September 18, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite medical publications’ importance to communicating key clinical data to the medical community, drug and device companies often track only volume-based metrics — leading to potentially missed...